Chisako Ito

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Unprecedented Megakaryocytic Blast Phase Transformation in Chronic Myeloid Leukemia After 16 Years of Tyrosine Kinase Inhibitor Therapy.

Unprecedented Megakaryocytic Blast Phase Transformation in Chronic Myeloid Leukemia After 16 Years of Tyrosine Kinase Inhibitor Therapy.

Journal: Cureus
Published: August 21, 2024

The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone.

The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone.

Journal: Hematology reports
Published: August 17, 2024

A predictive model for HIV-related lymphoma.

A predictive model for HIV-related lymphoma.

Journal: AIDS (London, England)
Published: June 04, 2024

Polatuzumab vedotin and bendamustine (Pola-B) was effective for refractory CD20-negative double-expressor lymphoma.

Polatuzumab vedotin and bendamustine (Pola-B) was effective for refractory CD20-negative double-expressor lymphoma.

Journal: Annals of hematology
Published: April 28, 2024

Pioneering cord blood transplantation in relapsed/refractory HIV-related lymphoma: a case study with concurrent intramuscular antiretroviral therapy.

Pioneering cord blood transplantation in relapsed/refractory HIV-related lymphoma: a case study with concurrent intramuscular antiretroviral therapy.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 30, 2024

Overcoming post-transplant graft failure and adenovirus infection in a patient with FLT3-TKD-mutated mixed-phenotype acute leukemia: A case report.

Overcoming post-transplant graft failure and adenovirus infection in a patient with FLT3-TKD-mutated mixed-phenotype acute leukemia: A case report.

Journal: EJHaem
Published: February 29, 2024

Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report.

Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report.

Journal: Annals of hematology
Published: February 23, 2024

Adipopenia is associated with poor outcomes in elderly patients with B-cell lymphoma.

Adipopenia is associated with poor outcomes in elderly patients with B-cell lymphoma.

Journal: Annals of hematology
Published: December 02, 2023

Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.

Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.

Journal: Annals of hematology
Published: June 03, 2023

Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma.

Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma.

Journal: Annals of hematology
Published: October 08, 2022

The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine.

The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine.

Journal: Annals of hematology
Published: September 12, 2020

The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine.

The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine.

Journal: Hematological oncology
Published: May 04, 2020
Showing 1-12 of 31

Last Updated: 09/26/2026